Barriers to opioid substitution treatment access, entry and retention: A survey of opioid users, patients in treatment, and treating and non-treating physicians

European Addiction Research

Volumn 17, Issue 1, 2010, Pages 44-54

  Stöver, Heino ^a  

^a FRANKFURT UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Buprenorphine; Evidence based guidelines; Methadone; Opiate related disorders

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; LEVOMETHADONE; METHADONE;

ACCREDITATION; ADULT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG USE; FEMALE; GERMANY; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; INTERVIEW; MALE; NORMAL HUMAN; OPIATE ADDICTION; OPIOID SUBSTITUTION TREATMENT; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; FEMALE; GERMANY; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS; HUMANS; MALE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PHYSICIANS; TREATMENT REFUSAL;

EID: 77958149835     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320576     Document Type: Article

References (32)

1. Ward J, Mattick RP, Hall W (eds): Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam, Harwood Academic Publishers, 1998.
2. McLellan A, O'Brien C, Metzger D, Alterman A, Cornish J: How effective is substance abuse treatment - compared to what?; in O'Brien CP, Jaffe JH (eds): Addictive States. New York, Raven Press, 1992, pp 231-252.
3. Facy F, Rosch D, Angel P, Touzeau D, Cordonnier JP, Petit F: Drug addicts attending specialised institutions: towards a drug addiction data bank? Drug Alcohol Depend 1991; 27: 43-50.
4. Dyer KR, White JM: Patterns of symptom complaints in methadone maintenance patients. Addiction 1997; 92: 1445-1455.
5. Weatherburn D, Lind B: The impact of law enforcement activity on a heroin market. Addiction 1997; 92: 557-569.
6. Dyer KR, Cruickshank C: Depression and other psychological health problems among methamphetamine dependent patients in treatment: implications for assessment and treatment. Aust Psychol 2005; 40: 96-108.
7. Schutz CG, Rapiti E, Vlahov D, Anthony JC: Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend 1994; 36: 129-138.
8. Strang J, Sheridan J, Hunt C, Kerr B, Gerada C, Pringle M: The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales. Br J Gen Pract 2005; 55: 444-451.
9. Turner BJ, Laine C, Lin YT, Lynch K: Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence. Arch Intern Med 2005; 165: 1769-1776.
10. European Monitoring Centre for Drugs and Drug Addiction: Estimates of prevalence of problem drug use at national level: summary table, 2002-06, rate per 1000 aged 15-64. http://www.emcdda.europa.eu; accessed on 29 July 2010.
11. Eurostat; Total population. . ec.europa.eu/tgm/information.do;jsessi onid=9ea7971b30e67540f447a6b0495db00e ec80e076141.e34RaNaLaN0Mc40LcheTaxi LbN4Re0?tab=table&plugin=0&language= en&pcode=tps00001; accessed on 29 July 2010.
12. Michels II, Stöver H, Gerlach R: Substitution treatment for opioid dependents in Germany. Int J Harm Reduct 2007; 4: 5.
13. Schulte B, Gansefort D, Stöver H, Reimer J: Strukturelle Hemmnisse in der Substitution und infektiologischen Versorgung substituierter Opiatabhängiger. Suchttherapie 2009; 10: 125-130.
14. Arif A, Cooper J, Maddux J: International overview and analysis of methadone role; in Arif A, Westermeyer J (eds): Methadone Maintenance in the Management of Opioid Dependence. New York, Praeger, 1990.
15. Yancovitz SR, Des J, Peyser NP, Drew E, Friedmann P, Trigg HL, Robinson JW: A randomized trial of an interim methadone maintenance clinic. Am J Public Health 1991; 81: 1185-1191.
16. Uchtenhagen A: Policy and practice of methadone maintenance: an analysis of worldwide experience; in Arif A, Westermeyer J (eds): Methadone Maintenance in the Management of Opioid Dependence. New York, Praeger, 2009.
17. Fisher DG, Anglin MD: Survival analysis in drug program evaluation. I. Overall program effectiveness. Int J Addict 1987; 22: 115-134.
18. Glanz M, Klawansky S, McAullife W, Chalmers T: Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials. Am J Addict 1997; 6: 339-349.
19. Caplehorn JR, Bell J, Kleinbaum DG, Gebski VJ: Methadone dose and heroin use during maintenance treatment. Addiction 1993; 88: 119-124. (Pubitemid 23102102)
20. Dyer KR, Foster DJ, White JM, Somogyi AA, Menelaou A, Bochner F: Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships. Clin Pharmacol Ther 1999; 65: 685-694.
21. Maddux J: Improving retention on methadone maintenance; in Inciardi JA, Tims F, Fletcher B (eds): Innovative Approaches in the Treatment of Drug Abuse. Westport, Greenwood Press, 1993.
22. Condelli WS: Strategies for increasing retention in methadone programs. J Psychoactive Drugs 1993; 25: 143-147.
23. Bell J, Chan J, Kuk A: Investigating the influence of treatment philosophy on outcome of methadone maintenance. Addiction 1995; 90: 823-830.
24. Szapocznik J, Ladner R: Factors related to successful retention in methadone maintenance: a review. Int J Addict 1977; 12: 1067-1085.
25. Mattick RP, Ali R, Lintzeris N: Pharmacotherapies for the Treatment of Opioid Dependence. New York, Informa, 2009.
26. Gaughwin M, Solomon P, Ali R: Correlates of retention on the South Australian Methadone Program 1981-91. Aust N Z J Public Health 1998; 22: 771-776.
27. Walley AY, Alperen JK, Cheng DM, Botticelli M, Castro-Donlan C, Samet JH, Alford DP: Office-based management of opioid dependence with buprenorphine: clinical practices and barriers. J Gen Intern Med 2008; 23: 1393-1398.
28. McNeely J, Drucker E, Hartel D, Tuchman E: Office-based methadone prescribing: acceptance by inner-city practitioners in New York. J Urban Health 2000; 77: 96-102.
29. Pidd K, Freeman T, Skinner N, Addy D, Shoobridge J, Roche AM: From training to work practice change: an examination of factors influencing training transfer in the alcohol and other drugs field. Canberra, Australian Government Department of Health and Ageing, 2004.
30. Jippes E, Achterkamp MC, Brand PL, Kiewiet DJ, Pols J, van Engelen JM: Disseminating educational innovations in health care practice: training versus social networks. Soc Sci Med 2010; 70: 1509-1517.
31. Ridge G, Gossop M, Lintzeris N, Witton J, Strang J: Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence. J Subst Abuse Treat 2009; 37: 95-100.
32. Becker WC, Fiellin DA: Provider satisfaction with office-based treatment of opioid dependence: a systematic review. Subst Abus 2005; 26: 15-22.